Drugplain

Meijer Advanced Redness and Irritation Relief .1 g/100mL

Dextran 70, Polyethylene glycol 400, Povidone, Tetrahydrozoline HCI · SOLUTION/ DROPS · Meijer Distribution, Inc.

No Recall History
Plain English

Meijer Advanced Redness and Irritation Relief is a solution/ drops containing dextran 70, polyethylene glycol 400, povidone, tetrahydrozoline hci at .1 g/100mL, taken ophthalmic. Manufactured by Meijer Distribution, Inc..

Key Facts

Brand Name
Meijer Advanced Redness and Irritation Relief
Generic Name
Dextran 70, Polyethylene glycol 400, Povidone, Tetrahydrozoline HCI
NDC Code (Product)
41250-594
Manufacturer
Meijer Distribution, Inc.
Strength
.1 g/100mL
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Marketing Status
Application #
M018
Drug Class
Plasma Volume Expander [EPC]
Marketing Start
03/06/2020

Recall History

No Recall History

Frequently Asked Questions

What is Meijer Advanced Redness and Irritation Relief used for?

Meijer Advanced Redness and Irritation Relief contains Dextran 70, Polyethylene glycol 400, Povidone, Tetrahydrozoline HCI. It is a solution/ drops taken ophthalmic. Consult your doctor for specific uses.

Is Meijer Advanced Redness and Irritation Relief a controlled substance?

Meijer Advanced Redness and Irritation Relief is not classified as a controlled substance by the DEA.

What is the generic name for Meijer Advanced Redness and Irritation Relief?

The generic name for Meijer Advanced Redness and Irritation Relief is Dextran 70, Polyethylene glycol 400, Povidone, Tetrahydrozoline HCI. There are 1 other brand versions of Dextran 70, Polyethylene glycol 400, Povidone, Tetrahydrozoline HCI.

What is the NDC code for Meijer Advanced Redness and Irritation Relief .1 g/100mL?

The NDC (National Drug Code) for Meijer Advanced Redness and Irritation Relief .1 g/100mL is 41250-594, listed by Meijer Distribution, Inc..

Product NDC

41250-594

Package NDC

41250-594-01

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)